Cargando…

Long-Term Outcome of Treatment with 2% Topical Ganciclovir Solution in Cytomegalovirus Anterior Uveitis and Corneal Endotheliitis

PURPOSE: This study aimed to evaluate the therapeutic efficacy and long-term outcomes of treatment with topical 2% ganciclovir solution in immunocompetent patients with aqueous humor polymerase chain reaction (PCR)-proven cytomegalovirus (CMV) anterior uveitis and corneal endotheliitis. METHODS: We...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Po-Jui, Lin, I-Huang, Chi, Yi-Chun, Lai, Chun-Chieh, Hung, Jia-Horung, Tseng, Sung-Huei, Huang, Yi-Hsun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250767/ https://www.ncbi.nlm.nih.gov/pubmed/35791348 http://dx.doi.org/10.2147/IDR.S370905

Ejemplares similares

Efficacy and safety of topical ganciclovir in the management of cytomegalovirus (CMV)-related anterior uveitis
por: Wong, John X. H., et al.
Publicado: (2016)

Effectiveness of Topical Ganciclovir 2% Monotherapy Versus Combined Steroid Therapy in Cytomegalovirus Endotheliitis
por: Kuo, Yu-Wei, et al.
Publicado: (2022)

Cytomegalovirus anterior uveitis in immunocompetent individuals following topical prostaglandin analogues
por: Babu, Kalpana, et al.
Publicado: (2013)

Efficacy and safety of an extemporaneous preparation of 2% ganciclovir eye drops in CMV anterior uveitis
por: Keorochana, Narumon, et al.
Publicado: (2017)

Requirement of longer term antiviral therapy in patients with cytomegalovirus anterior uveitis with corneal endothelial cell damage
por: Harada, Yosuke, et al.
Publicado: (2018)

A double masked randomised 4-week, placebo-controlled study in the USA, Thailand and Taiwan to compare the efficacy of oral valganciclovir and topical 2% ganciclovir in the treatment of cytomegalovirus anterior uveitis: study protocol
por: Takhar, Jaskirat S, et al.
Publicado: (2019)

Ganciclovir/letermovir: Rebound Cytomegalovirus hepatitis, acquired resistance to ganciclovir and nephrotoxicity: case report
Publicado: (2020)

Ganciclovir-resistant cytomegalovirus infection in renal transplantation
por: Vaz, Raquel, et al.
Publicado: (2014)

Intra-cameral level of ganciclovir gel, 0.15% following topical application for cytomegalovirus anterior segment infection: A pilot study
por: Waduthantri, Samanthila, et al.
Publicado: (2018)

Treatment of cytomegalovirus anterior segment infection with intravitreal injection of ganciclovir in adjunction with or without oral valganciclovir: a long-term results
por: Cheng, Yu-Chun, et al.
Publicado: (2021)

Presumed neonatal cytomegalovirus retinitis treated with intravenous ganciclovir
por: Suganya, A, et al.
Publicado: (2020)

Preemptive ganciclovir for mechanically ventilated patients with cytomegalovirus reactivation
por: Papazian, Laurent, et al.
Publicado: (2021)

Overview and update on cytomegalovirus-associated anterior uveitis and glaucoma
por: Ye, Zifan, et al.
Publicado: (2023)

Treatment outcomes of reduced-dose intravitreal ganciclovir for cytomegalovirus retinitis
por: Choopong, Pitipol, et al.
Publicado: (2016)

Ganciclovir penetrates into the cerebrospinal fluid of an infant with congenital cytomegalovirus infection
por: Natale, Fabio, et al.
Publicado: (2015)

Topical ganciclovir in the treatment of acute herpetic keratitis
por: Tabbara, Khalid F, et al.
Publicado: (2010)

Cytomegalovirus as a cause of hypertensive anterior uveitis in immunocompetent patients
por: Choi, Jin A, et al.
Publicado: (2016)

Outcome of Cytomegalovirus Colitis in Inflammatory Bowel Disease with Different Regimes of Ganciclovir
por: Ahmed, Iftikhar, et al.
Publicado: (2018)

Standard ganciclovir dosing results in slow decline of cytomegalovirus viral loads
por: Märtson, Anne-Grete, et al.
Publicado: (2021)

Real-time polymerase chain reaction in recurrent cytomegalovirus anterior uveitis
por: Rao, Vinita Girish, et al.
Publicado: (2019)

Cytomegalovirus Anterior Uveitis: Clinical Manifestations, Diagnosis, Treatment, and Immunological Mechanisms
por: Zhang, Jing, et al.
Publicado: (2023)

The effects of maribavir on the autophosphorylation of ganciclovir resistant mutants of the cytomegalovirus UL97 protein
por: Shannon-Lowe, Claire D, et al.
Publicado: (2010)

Successful Treatment with Ganciclovir for Cytomegalovirus Duodenitis following Allogenic Bone Marrow Transplantation
por: Ahn, Jin Hee, et al.
Publicado: (1999)

Cytomegalovirus-associated esophageal ulcer in an immunocompetent infant: When should ganciclovir be administered?
por: Jang, Hyo-Jeong, et al.
Publicado: (2012)

Therapeutic Drug Monitoring of Ganciclovir Treatment for Cytomegalovirus Infections Among Immunocompromised Children
por: Stockmann, Chris, et al.
Publicado: (2016)

Predictor of Liver Biochemistry Improvement in Patients with Cytomegalovirus Cholestasis after Ganciclovir Treatment
por: Puspita, Gina, et al.
Publicado: (2022)

Cytomegalovirus as a possibly overlooked agent of hypertensive anterior uveitis and endotheliitis in immunocompetent patients in Brazil
por: dos Reis, Caroline, et al.
Publicado: (2021)

Cytomegalovirus Retinitis in an ALL Child during Maintenance Therapy Treated Successfully with Intravenous Ganciclovir
por: Celiker, Hande, et al.
Publicado: (2014)

Efficacy of valganciclovir and ganciclovir for cytomegalovirus disease in solid organ transplants: A meta-analysis
por: Vaziri, Siavash, et al.
Publicado: (2014)

Leflunomide: a treatment option for ganciclovir-resistant cytomegalovirus infection after renal transplantation
por: Andrassy, Joachim, et al.
Publicado: (2009)

Cytomegalovirus myocarditis in a patient with systemic lupus erythematosus (SLE) successfully treated with ganciclovir
por: Saraca, Lavinia Maria, et al.
Publicado: (2018)

Initial intravitreal injection of high-dose ganciclovir for cytomegalovirus retinitis in HIV-negative patients
por: Qian, Zhuyun, et al.
Publicado: (2018)

Cytomegalovirus Myocarditis Required Extracorporeal Membrane Oxygenation Support Followed by Ganciclovir Treatment in Infant
por: Kim, Bong Jun, et al.
Publicado: (2016)

1753. Neutropenia as a Function of Ganciclovir Exposure During Treatment of Congenital Cytomegalovirus Disease
por: Nishikawa, Javier K, et al.
Publicado: (2023)

Overweight and Obesity as Risk Factors for Recurrent Herpetic Stromal Keratitis during Long-Term Antiviral Prophylaxis
por: Hsu, Chiung-Ju, et al.
Publicado: (2022)

Potential Factors of Corneal Endothelial Cells for Progression in Children with Uveitis
por: Chen, Xu, et al.
Publicado: (2021)

Scleritis and anterior uveitis may herald the development of an epibulbar tumor in patients with extranodal Rosai-Dorfman disease: a case report
por: Lee, Yu-Kuei, et al.
Publicado: (2019)

Ganciclovir-resistant CMV (GCV-R CMV) Infection Leads to Poor Clinical Outcomes and Economic Burden of Ganciclovir-resistant Cytomegalovirus Infection in Lung Transplant Recipients
por: Patel, Twisha, et al.
Publicado: (2017)

Retinal and Corneal Toxicity and Pharmacokinetic Analysis of Intraocular Injection of Ganciclovir in Rabbit Eyes
por: Sun, Bin-jia, et al.
Publicado: (2019)

Management of cytomegalovirus corneal endotheliitis
por: Wong, Angela H. Y., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_68mksil15vt9fqo7muaqfjmkm4